Lam Research (LRCX) Stock Surges Past $300 Milestone as Wall Street Boosts Price Targets
📈 Lam Research (LRCX) shares surged past the $300 milestone for the first time in company history, reaching a record intraday peak of $300.06 on May 14.
🚀 The stock has climbed approximately 250% over the trailing twelve months and gained 73% since January alone.
📊 Third-quarter fiscal results exceeded Wall Street expectations with earnings per share of $1.47 versus a forecast of $1.36.
💰 Quarterly revenue reached $5.84 billion, representing a 23.8% year-over-year increase for the semiconductor equipment maker.
🏦 B. Riley Financial elevated its price objective to $375 from $350 while maintaining its Buy recommendation.
💼 Among the 34 Wall Street analysts tracking LRCX, 26 recommend buying and eight recommend holding positions.
📈 The average price target sits at $291.75, though numerous firms have established objectives substantially higher than this average.
🔬 Major banks including Stifel, TD Cowen, Citigroup, Cantor Fitzgerald, Sanford C. Bernstein, and UBS all maintained Buy ratings with targets ranging from $300 to $340.
💼 Corporate insiders collectively divested $27.9 million in stock during the most recent quarter, representing 0.31% of outstanding shares.
🏛️ Institutional investors and hedge funds currently control 84.61% of Lam Research shares, with several firms establishing fresh positions recently.
💹 Lam Research commands a market capitalization of $372.7 billion as of the latest data.
⚠️ American semiconductor equipment manufacturers face ongoing obstacles due to Department of Commerce restrictions on tool shipments to China's Hua Hong.
🔮 Cantor Fitzgerald anticipates wafer fabrication equipment spending growth exceeding 27% in 2026, which could benefit Lam Research orders.
🤖 UBS drew comparisons between LRCX and AI-driven expansion cycles experienced by Nvidia and Broadcom.
🧐 InvestingPro data suggests LRCX currently trades above its calculated Fair Value estimate despite positive analyst sentiment.
- Lam Research (LRCX) shares surged past $300 for the first time in company history on May 14, reaching an intraday peak of $300.06.
- The stock has delivered approximately 250% returns over the trailing twelve months and gained 73% since January 2025 alone.
- Fiscal third-quarter results exceeded Wall Street expectations with earnings per share of $1.47 versus the $1.36 forecast, alongside revenue of $5.84 billion representing a 23.8% annual increase.
- Management raised fourth-quarter fiscal guidance to between $1.50 and $1.80 per share, exceeding market expectations.
- Gross profit margins are nearing the 50% mark with management forecasting continued expansion.
- Among 34 Wall Street analysts tracking the company, 26 recommend buying while numerous firms including TD Cowen, Stifel, and Citigroup recently boosted their price targets above current levels.
- Cantor Fitzgerald anticipates wafer fabrication equipment spending growth exceeding 27% in 2026, which potentially benefits Lam Research's future orders despite sector challenges.
- B. Riley Financial elevated its price objective to $375 from $350 while maintaining its Buy recommendation following the announcement.
- Company insiders collectively disposed of 120,066 shares valued at $27.95 million during the latest quarter, including CFO Douglas Bettinger selling 50,057 shares and Executive Ava Harter selling 6,010 shares.
- Institutional ownership comprises 84.61% of shares, indicating heavy concentration among large investors that could lead to sharp price declines if sentiment shifts.
- The stock trades above its calculated Fair Value estimate according to InvestingPro data, suggesting the current $372.7 billion market cap may be overvalued relative to fundamentals.
- Persistent challenges remain regarding Department of Commerce restrictions on tool shipments to China's Hua Hong, creating ongoing geopolitical risk for the company's operations.
- Despite a record price milestone, only 26 out of 34 analysts recommend buying LRCX, with eight analysts maintaining Hold positions and potential divergence from the bullish consensus.
- Rising stock price over 12 months (250% climb) may attract regulatory scrutiny or trigger short-selling pressure as valuation extends further from historical averages.